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Abstract
Objectives: COVID-19 outbreak brings a challenge to healthcare systems. The sex, age, and cardiometabolic comorbidities have been considered risk factors for disease severity. To evaluate the association between risk factors with
death as well the risk of death in hospitalized COVID-19 patients.
Methods: The present cross-sectional cohort study, includes hospitalized SARS-CoV-2 conﬁrmed cases. Data analysis
was performed using the National COVID-19 Cases Report Database. Pearson's c2 test and odds ratios (95% CI) were
calculated to determine the association between variables. Thereafter, risk of death was evaluated by Cox proportional
hazards model.
Results: A total of 67 328 inpatients were included; mean age 55.29 years (±15.97). Of total, 42 164 (62.62%) were men, 6
349 (9.43%) were intubated, and 23 873 (35.46%) died. Male sex, age older than 60 years, and cardiometabolic comorbidities were associated with death. Hazard ratio for death in older intubated patients was lower than in non-intubated
(HR 1.242, 95%CI, 1.167e1.322; P < 0.001) and (HR 2.128, 95%CI, 2.066e2.193; P < 0.001) respectively.
Conclusions: Tracheal intubation or not is the most important predictor for death in COVID-19 infected patients in this
Mexican cohort. Already known risk factors for COVID-19 severity may become less relevant once patients require
tracheal intubation.
Keywords: COVID-19, SARS-CoV-2, Tracheal intubation, Risk factors, Death

1. Introduction

C

OVID-19, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2),
shows a global case fatality rate of 4.9%, although
in countries like Mexico or Italy has been reported as high as 12.3% and 14.45%, respectively.
At present (July 13th, 2020), COVID-19 has
affected 13 070 590 people and has caused 572 428
deaths [1]. Therefore, the ongoing COVID-19
outbreak brings a big challenge to the hospital
services, in particular intensive care units (ICU).
In order to optimize the availability of ICU

resources could be imperative to identify patients
at high risk of progressing to severe and critical
stages [2]. Tracheal intubation in COVID-19 patients seems to be a risk to physiologically
compromised patients [3,4]. In addition, comorbidities including diabetes, obesity, and hypertension have been associated with poor clinical
outcomes [5]. An older age, diabetes and history
of cardiovascular disease, especially hypertension, but also chronic heart failure and coronary
artery disease among others, are between the
most important risk factors for COVID-19 mortality [6e8]. In Mexico, as in other developing
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countries with a high burden of these cardiometabolic comorbidities, the scenario seems to
be aggravated [1,5,6]. Thus, we aimed to evaluate
if age, sex, and preexisting comorbidities are risk
factors for death in a Mexican cohort of hospitalized patients, as well as in intubated patients
with COVID-19.

2. Methods
The present is a cross-sectional cohort study,
including adult (>18 years) hospitalized SARS-CoV2 conﬁrmed cases of all ages from February 28th to
June 29th, 2020. The infection was conﬁrmed by
reverse transcription polymerase chain reaction
(RT-PCR), performed according to the protocol
approved by the Institute of Epidemiological Diagnosis and Reference [9]. Data analysis was carried
out using the National COVID-19 Cases Report
Database (Mexican Department of Epidemiology)
which is of public access [9,10]. Foreign subjects
were excluded from the analyses, and incomplete
data from the database were eliminated.
2.1. Statistical Analysis
The statistical analysis was performed by using
the SPSS 24.0 software (IBM, USA). Pearson's c2 test
and odds ratios (OR) with 95% conﬁdence intervals
(CI) were calculated to determine the association
between age, sex, tracheal intubation, and comorbidities (diabetes, hypertension and obesity) with
death in hospitalized patients. Age was considered
as a categorical variable (<60, 60 years old) in all
the analyses. Thereafter, the risk of death was
evaluated by Cox proportional hazards model in
intubated patients in comparison with non-intubated patients. Values of p < 0.05 were considered
statistically signiﬁcant.

3. Results
Until June 29th, 220 657 SARS-CoV-2 accumulated
conﬁrmed cases were registered in Mexico. Of total,
68 296 (30.95%) patients have required hospital care.
Of total inpatient SARS-CoV-2 conﬁrmed cases, 161
foreigners (0.24%) were excluded; and 807 cases
(1.18%) were eliminated because of incomplete data.
Thus, a total of 67 328 COVID-19 inpatients were
included in the analyses. The mean age was
55.29 years (±15.97), 42 164 (62.62%) were men, and
the total number of deaths was 23 873 (35.46%). Of
hospitalized patients, 6 349 (9.43%) required
tracheal intubation. The mean age of intubated patients was 57.16 years (±15.25), 4 292 (67.60%) were
males, and 4 280 (67.41%) died.
The present analysis showed that sex, age, hypertension, diabetes, obesity, and tracheal intubation were signiﬁcantly associated with death in
COVID-19 hospitalized patients (Table 1).
Survival analysis of hospitalized patients that
didn't require tracheal intubation showed that men
with SARS-CoV-2 infection had a higher risk of
death in comparison with women (HR 1.240, 95%CI,
1.204 to 1.277; P < 0.001). Age older than 60 years
was associated with more than double the risk of
mortality (HR 2.128, 95%CI, 2.066 to 2.193; P < 0.001).
In addition, hypertension (HR 1.257, 95%CI, 1.218 to
1.297; P < 0.001), diabetes (HR 1.207, 95%CI, 1.170 to
1.245; P < 0.001), and obesity (HR 1.091, 95%CI, 1.055
to 1.128; P < 0.001), signiﬁcantly increased the risk of
death in non-intubated hospitalized patients (Fig. 1).
In contrast, the sex and hypertension were not
associated with an increased risk of death in intubated patients; (HR 1.064, 95%CI, 0.997 to 1.110;
P ¼ 0.062) and (HR 1.038, 95%CI, 0.971 to 1.110;
P ¼ 0.268), respectively. Intubated patients with age
older than 60 years, diabetes or obesity had a
discrete increased risk of death; (HR 1.242, 95%CI,
1.167 to 1.322; P < 0.001), (HR 1.135, 95%CI, 1.063 to

Table 1. Association of age, sex, comorbidities and intubation with death.
Total population: 67 328

Age,  60 years, n (%)
Sex, male, n (%)
Hypertension, n (%)
Diabetes, n (%)
Obesity, n (%)
Tracheal intubation, n (%)

c2 test

Death, n (%)
Yes

No

23 873 (35.5)

43 455 (64.5)

OR (95% CI)

RR (95% CI)

P value

13 528 (19.7)
15 676 (23.3)
10 140 (15.1)
8 893 (13.2)
5 910 (8.8)
4 280 (6.4)

14 293 (21.1)
26 488 (39.3)
13 011 (19.3)
11 867 (17.6)
9 981 (14.8)
2 069 (3.1)

2.563
1.225
1.728
1.580
1.103
4.370

1.809
1.141
1.409
1.332
1.065
2.098

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

(2.481e2.647)
(1.185e1.266)
(1.672e1.785)
(1.528e1.634)
(1.063e1.145)
(4.135e4.617)

(1.773e1.846)
(1.117e1.166)
(1.381e1.438)
(1.305e1.359)
(1.040e1.090)
(2.055e2.142)

COVID-19 hospitalized patients with age older than 60 years, male sex, comorbidities history (hypertension, diabetes and obesity) or
requiring tracheal intubation were more likely to death than SARS-CoV-2 hospitalized patients without those risk factors. Total population of SARS-CoV-2 conﬁrmed patients hospitalized in Mexico from February 28th to June 29th, 2020, according to National COVID19 Cases Report Database (Mexican Department of Epidemiology).

Fig. 1. Hazard ratio for death according to risk factors in hospitalized
SARS-CoV-2 patients, according to intubation requirement. HR, hazard
ratio. *P < 0.001.

1.211; P < 0.001), and (HR 1.150, 95%CI, 1.076 to
1.229; P < 0.001) (Fig. 1).
In addition, the survival analysis showed that the
age had a different impact on survival probability
between non-intubated and intubated population.
In intubated patients, survival probability was
drastically diminished regardless of age (Fig. 2).

4. Discussion
Retrospective observational studies have shown
that patients with COVID-19 who are older, male, or
diabetic are at higher risk of requiring intubation
[11,12]. The association was also pointed out in a
cross-sectional cohort study performed in Mexican
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population, identifying obesity as a risk factor for
mechanical ventilation [11]. In the same way, these
risk factors, including hypertension have been
associated with death in SARS-CoV-2 infected patients [13-15]. However, available data may not be
enough to mark safe conclusions on the prognosis of
COVID-19 patients who require mechanical ventilation [16].
The present results are in accordance with previous studies that recognize older age, male sex, hypertension, diabetes and obesity as risk factors for
death and severity in SARS-CoV-2 patients [17-20].
In addition, here we showed evidence of association
between the requirements of tracheal intubation
with death in COVID-19 patients. However, the sex
and hypertension seem to be clinically irrelevant
regarding the risk of death once the patient is
intubated. Likewise, the age of intubated patients
didn't appear to be as relevant as in non-intubated
population. This ﬁnding suggests that younger age
is not a protective factor in intubated patients as
occurs in hospitalized but not intubated population.
Obesity, unlike the other evaluated risk factors,
showed a higher HR in intubated patients. This may
be explained in part by the negative effects of
obesity in mechanics of the lungs and airway [21]. In
fact, COVID-19 severity has been correlated with
higher body mass index [22].
Although the limitations of this cross-sectional
cohort study, it may contribute to understand how
age, sex, and cardiometabolic risk factors inﬂuence
COVID-19 outcome in critically ill patients. Of note,
some of these risk factors for COVID-19 may

Fig. 2. Survival probability of patients with COVID-19, according to days from hospitalization date, age and intubation requirement.
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become clinically less relevant once patients deteriorate and require TI. Therefore, SARS-CoV-2
infection needs to be widely understood and further
evidences regarding the pathophysiology and risk
factors are still required.
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